Andere Sprachen BioDelivery Sciences International, Inc.

Aktien

766464

US09060J1060

BDSI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Tranche Update on BioDelivery Sciences International, Inc.'s Equity Buyback Plan announced on November 4, 2020.	05.05.22
Collegium Pharmaceutical Completes Acquisition of BioDelivery Sciences	23.03.22
BioDelivery Sciences International : Termination of a Material Definitive Agreement - Form 8-K	23.03.22
BIODELIVERY SCIENCES INTERNATIONAL INC : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	22.03.22
Collegium Completes the Acquisition of BDSI	22.03.22
BioDelivery Sciences International, Inc.(NasdaqGS:BDSI) dropped from NASDAQ Composite Index	22.03.22
BioDelivery Sciences International, Inc.(NasdaqGS:BDSI) dropped from S&P Global BMI Index	21.03.22
BioDelivery Sciences International, Inc.(NasdaqGS:BDSI) dropped from S&P TMI Index	21.03.22
Collegium Pharmaceutical, Inc. completed the acquisition of BioDelivery Sciences International, Inc. for approximately $670 million.	21.03.22
BioDelivery Sciences International, Inc.(NasdaqGS:BDSI) dropped from NASDAQ Biotechnology Index	18.03.22
BIODELIVERY SCIENCES INTERNATIONAL INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	09.03.22
Tranche Update on BioDelivery Sciences International, Inc.'s Equity Buyback Plan announced on November 4, 2020.	09.03.22
BioDelivery Sciences International, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	09.03.22
BioDelivery Sciences International Launches Oral Solution for Acute Treatment of Migraine in US	24.02.22
BioDelivery Sciences International Announces ELYXYB™ is Now Available in the U.S. for the Acute Treatment of Migraine	24.02.22
Biodelivery Sciences International Announces ELYXYB Is Now Available in the U.S. for the Acute Treatment of Migraine	24.02.22
BioDelivery Sciences International : Material Definitive Agreement - Form 8-K/A	15.02.22
BIODELIVERY SCIENCES INTERNATIONAL INC Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K/A)	15.02.22
Bam Bam Resources (NPEZF) could be well positioned to take advantage of the World Copper shortage	15.02.22
Collegium Pharmaceutical to Acquire BioDelivery Sciences in All-Cash Deal; Shares Jump	14.02.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen BioDelivery Sciences International, Inc.

Aktien

766464

US09060J1060

BDSI

Andere Sprachen

Filter